Concourse Capital Management adds Laboratory Corp. of America Holdings (LH) to its portfolio

Laboratory Corp. of America Holdings (LH) : Concourse Capital Management added new position in Laboratory Corp. of America Holdings during the most recent quarter end. The investment management firm now holds 14,695 shares of Laboratory Corp. of America Holdings which is valued at $2,059,210 , the company said in a statement filed on Aug 2, 2016 with the SEC.Laboratory Corp. of America Holdings makes up approximately 1.25% of Concourse Capital Management’s portfolio.

Other Hedge Funds, Including , Daiwa Securities Group reduced its stake in LH by selling 500 shares or 4.95% in the most recent quarter. The Hedge Fund company now holds 9,600 shares of LH which is valued at $1,320,960. Laboratory Corp. of America Holdings makes up approx 0.01% of Daiwa Securities Group’s portfolio. Jolley Asset Management added LH to its portfolio by purchasing 75 company shares during the most recent quarter which is valued at $10,412. Laboratory Corp. of America Holdings makes up approx 0.01% of Jolley Asset Management’s portfolio.Ami Asset Management Corp reduced its stake in LH by selling 7,508 shares or 3.27% in the most recent quarter. The Hedge Fund company now holds 222,238 shares of LH which is valued at $30,851,079. Laboratory Corp. of America Holdings makes up approx 2.06% of Ami Asset Management Corp’s portfolio.

Laboratory Corp. of America Holdings closed down -1.41 points or -1.00% at $139.35 with 7,92,565 shares getting traded on Monday. Post opening the session at $140.8, the shares hit an intraday low of $139.14 and an intraday high of $141.07 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Laboratory Corp. of America Holdings reported $2.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $2.30. The company had revenue of $2382.00 million for the quarter, compared to analysts expectations of $2334.01 million. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.09 EPS.

Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing patient diagnosis and in the monitoring and treatment of disease. The Company manages its operations through two segments: the Clinical diagnostics laboratory segment which includes core testing as well as genomic and esoteric testing; and the Other segment which consists of the Company’s non-United States clinical diagnostic laboratory operations in Ontario Canada. It also provides specialty testing services in the areas of allergy clinical trials diagnostic genetics women’s health cardiovascular disease identity forensics infectious disease endocrinology oncology coagulation occupational testing and pain management.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *